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In this work, a mono- and a bi-enzymatic analytical immobilized 
enzyme reactors (IMERs) were developed as prototypes for 
biosynthetic purposes and their performances in the in-flow synthesis 
of nucleoside analogues of pharmaceutical interest were evaluated. Two 
biocatalytic routes based on nucleoside 2′-deoxyribosyltransferase from 
Lactobacillus reuteri (LrNDT) and uridine phosphorylase from 
Clostridium perfrigens (CpUP)/purine nucleoside phosphorylase from 
Aeromonas hydrophila (AhPNP) were investigated in the synthesis of 
2′-deoxy, 2′,3′-dideoxy and arabinonucleoside derivatives. LrNDT-
IMER catalyzed the synthesis of 5-fluoro-2′-deoxyuridine and 5-iodo-
2′-deoxyuridine in 65–59% conversion yield, while CpUP/AhPNP-
IMER provided the best results for the preparation of 
arabinosyladenine (60% conversion yield). 
 
Both IMERs proved to be promising alternatives to chemical routes for 
the synthesis of nucleoside analogues. The developed in-flow system 
represents a powerful tool for the fast production on analytical scale of 
nucleosides for preliminary biological tests. 
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